To hear about similar clinical trials, please enter your email below
Trial Title:
Glioma Developmental and HyperActive Ras Tumor (DHART) Board
NCT ID:
NCT05489783
Condition:
Glioma
Conditions: Official terms:
Glioma
Conditions: Keywords:
NF1-associated glioma
Neurofibromatosis
Registry
22-199
Study type:
Observational [Patient Registry]
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Summary:
This study will collect medical records, scan results, and complete surveys to create a
registry about people with a neurofibromatosis type 1-associated brain tumor
(NF1-associated glioma). A registry is a collection of health information about
individuals, and it is usually focused on a specific diagnosis or condition.
This registry study will help the researchers learn more about the diagnosis, treatment,
and quality of life of people with NF1-associated glioma. The researchers want to
understand what happens as a result of different treatments for NF1-associated glioma and
how these treatments and the disease itself affect people's lives over a period of time.
Information collected during this study could affect how doctors diagnose, test, and
treat NF1-associated glioma, and the study could help future patients with this type of
cancer.
Criteria for eligibility:
Study pop:
Patients with NF1 glioma will be enrolled in this registry study.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Clinical diagnosis that meets NIH criteria for NF1 disease by either 1) documented
clinical record establishing NF1 or 2) self-reported with supported documentation
upon medical record collection.
- Willing to have historical and future NF1 related health records sent to registry
for review.
- Radiologic or pathologically confirmed glioma.
- Individuals ≥18 years of age on the date of informed consent.
Exclusion Criteria:
- Unwillingness to sign informed consent.
- No proficiency in English or Spanish as determined by the Investigator.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Address:
City:
Basking Ridge
Zip:
07920
Country:
United States
Status:
Recruiting
Contact:
Last name:
Anna Piotrowski, MD
Phone:
212-610-0483
Facility:
Name:
Memorial Sloan Kettering Monmouth (All protocol activities)
Address:
City:
Middletown
Zip:
07748
Country:
United States
Status:
Recruiting
Contact:
Last name:
Anna Piotrowski, MD
Phone:
212-610-0483
Facility:
Name:
Memorial Sloan Kettering Bergen (All Protocol Activities)
Address:
City:
Montvale
Zip:
07645
Country:
United States
Status:
Recruiting
Contact:
Last name:
Anna Piotrowski, MD
Phone:
212-610-0483
Facility:
Name:
Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
Address:
City:
Commack
Zip:
11725
Country:
United States
Status:
Recruiting
Contact:
Last name:
Anna Piotrowski, MD
Phone:
212-610-0483
Facility:
Name:
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Address:
City:
New York
Zip:
10065
Country:
United States
Status:
Recruiting
Contact:
Last name:
Anna Piotrowski, MD
Phone:
212-610-0483
Contact backup:
Last name:
Ingo Mellinghoff, MD
Phone:
646-888-3036
Facility:
Name:
Memorial Sloan Kettering Nassau (All Protocol Activities)
Address:
City:
Rockville Centre
Zip:
11570
Country:
United States
Status:
Recruiting
Contact:
Last name:
Anna Piotrowski, MD
Phone:
212-610-0483
Facility:
Name:
Memorial Sloan Kettering West Harrison (All Protocol Activities)
Address:
City:
West Harrison
Zip:
10604
Country:
United States
Status:
Recruiting
Contact:
Last name:
Anna Piotrowski, MD
Phone:
212-610-0483
Start date:
July 29, 2022
Completion date:
July 29, 2025
Lead sponsor:
Agency:
Memorial Sloan Kettering Cancer Center
Agency class:
Other
Source:
Memorial Sloan Kettering Cancer Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05489783
https://www.mskcc.org/
